Non‑small cell lung cancer (NSCLC) accounts for~ 85% of lung cancer cases and has high
morbidity and mortality rates. Over the past decade, treatment strategies for NSCLC have …

In the past 20 years, the International Association for the Study of Lung Cancer (IASLC) has
been working on a global project to revise the TNM classification of lung cancer. The first …

Objective Our aim was to validate the prognostic relevance in NSCLC of potential residual
tumor (R) descriptors, including the proposed International Association for the Study of Lung …

Background: We proposed a population graph with Transformer-generated and clinical
features for the purpose of predicting overall survival (OS) and recurrence-free survival …

Background Mutation of the EGFR gene is known as a predictor for the response to EGFR
tyrosine kinase inhibitor. Although EGFR mutation status is proposed to be incorporated in …

Introduction An international database was created by the International Association for the
Study of Lung Cancer to inform on the ninth edition of the TNM classification of lung cancer …

With an estimated 2.2 million worldwide cases and 1.9 million deaths in 2017, lung cancer is
the leading cause of cancer mortality in most countries. 1 In the aggregate, 5-year survival of …

Introduction Current nodal staging of NSCLC is defined only by anatomical location of lymph
nodes (LNs). The aim of this study is to investigate prognostic impacts of the number of …

Introduction The accurate assessment of nodal (N) status is crucial to the management and
prognostication of nonmetastatic NSCLC. We sought to determine whether the current N …

OBJECTIVES We queried the European Society of Thoracic Surgeons (ESTS) prospective
thymic database for descriptive analysis and for comparison with the ESTS retrospective …